title: Size of the direct-to-consumer genomic testing market.
abstract: There has been enormous interest in the recent development of consumer genomics services, but very little is known about their impact. Using publicly available information, we estimate that the market for genetic susceptibility tests for complex diseases is much smaller than previously suggested, and hence consider that regulation through restrictive statutory legislation may be excessive.
authors.affiliation: PHG Foundation, Cambridge, United Kingdom. caroline.wright@phgfoundation.org
authors.forename: Caroline F
authors.initials: CF
authors.lastname: Wright
authors.forename: Shelley
authors.initials: S
authors.lastname: Gregory-Jones
mesh_terms: D003254:Consumer Advocacy; D020022:Genetic Predisposition to Disease; D030661:Genetic Privacy; D005820:Genetic Testing / Q000331:legislation & jurisprudence* / Q000379:methods / Q000639:trends; D015894:Genome, Human; D023281:Genomics / Q000379:methods; D006801:Humans; D008389:Marketing of Health Services